Mini Review
Published on 14 Apr 2020
Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00443
- 17,923 views
- 28 citations
10 articles related to "D816v"
Articles
Case Report
Published on 18 Oct 2024
Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1401187
- 4,562 views
- 1 citation
Original Research
Accepted on 19 Feb 2026
Molecular characterization of pediatric mastocytosis revealed different somatic mutations with uncertain prognostic value
in Molecular and Cellular Pathology
Frontiers in Cell and Developmental Biology
Case Report
Published on 10 Aug 2023
Case Report: Molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1210909
- 5,088 views
- 3 citations
Review
Published on 27 May 2025
Utility of tryptase genotyping in the screening, diagnosis, and management of systemic mastocytosis
in Genetics and Epidemiology
Frontiers in Allergy
doi 10.3389/falgy.2025.1599358
- 3,829 views
- 2 citations
Review
Published on 20 Jul 2017
Targeted Treatment Options in Mastocytosis
in Hematology
Frontiers in Medicine
doi 10.3389/fmed.2017.00110
- 17,850 views
- 27 citations
Original Research
Published on 28 Mar 2018
Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2018.00631
- 5,862 views
- 9 citations
Case Report
Published on 30 Nov 2021
Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.734025
- 3,217 views
Original Research
Published on 26 Jul 2022
The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2022.930945
- 6,171 views
- 16 citations
Case Report
Published on 29 May 2018
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2018.01198
- 7,153 views
- 19 citations